Arch Therapeutics Inc (ARTH)

[formerdtrader]

Agree with you brahm, but you have to be patient. Without the news that pushes this stock through barriers, it will be range bound. The first is the CE application, then the CE approval, the FDA approval and the partnership with a manufacturing/distribution partner.

2017 will be the year we see a lot of this through, but it is a hard stock to watch every hour on the hour, day by day waiting for those milestones.